Skip to main content
. Author manuscript; available in PMC: 2019 Aug 1.
Published in final edited form as: Health Psychol. 2018 Aug;37(8):701–715. doi: 10.1037/hea0000637

Table 1.

Frequencies of demographic, outcome, and moderator variables in hazard ratio and odds ratio studies.

Number (%) of effects unless otherwise noted Hazard Ratio Effects (k=15) Odds Ratio Effects (k=62)
Participants
 Total number across all effects 203,017 555,532
Mdn, [range] 6,407 [3,032–37,699] 2,209 [192–53,998]
 Total female participants across all effects 153,952 (75.8%) 323,920 (58.3%)
 Non-U.S. samples 13 (87.0%) 28 (45.2%)
 % participants who report 2+ adversities, M (SD) 25.0% (18.0%)a 30.0% (21.4%)b
Study Design
 Retrospective assessment of adversity 15 (100%) 56 (90.3%)
 Years of follow-up, M (SD) 10.0 (4.4)c 19.9 (13.0)d
Outcomes
 CVD clinical outcomes 12 (80.0%) 36 (58.1%)
 Metabolic outcomes 3 (20.0%) 26 (41.9%)
 Independently-assessed disease 8 (53.3%) 22 (35.5%)
Cumulative Adversity Index
 Total number of items, M (SD) 7.4 (3.2) 9.81 (6.0)
 ACE Questionnaire vs. Others 3 (20.0%) 36 (58.1%)
 Index included childhood SES 11 (73.3%) 13 (21.0%)
 Index included household dysfunction 10 (66.7%) 48 (77.4%)
 Index included abuse/neglect 8 (53.3%) 58 (93.5%)
Analytic Strategy
 Comparison of most vs. least adversities 14 (93.3%) 48 (77.4%)
 Number of covariates in analytic models, M (SD) 8.3 (4.0) 5.2 (4.4)
 Covariate type: Adult SES 13 (86.7%) 46 (74.2%)
 Covariate type: Psychosocial 11 (73.3%) 22 (35.5%)
 Covariate type: Health behaviors 10 (66.7%) 22 (35.5%)
a

Reflects data from 7 out of 15 effects that provided sufficient information.

b

Reflects data from 47 out of 62 effects that provided sufficient information.

c

Reflects data from 6 out of 9 studies that provided sufficient information.

d

Reflects data from 10 out of 29 studies, including both retrospective and prospective designs, that provided sufficient information.